BRPI0823193A2 - inibidores de protease de bowman birk variantes modificados - Google Patents

inibidores de protease de bowman birk variantes modificados

Info

Publication number: BRPI0823193A2
Authority: BR; Brazil
Prior art keywords: protease inhibitors; modified variant; bowman birk; birk protease; variant bowman
Prior art date: 2008-10-15

Application number

BRPI0823193A

Other languages

English (en)

Inventor

F Schmidt Brian

Fox Bryan

A Estell David

Vogtentanz Gudrun

D Collier Katherine

Estabrook Melodie

S Amin Neelam

D Power Scott

Original Assignee

Danisco Us Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-15

Filing date

2008-10-15

Publication date

2019-09-24

2008-10-15 Application filed by Danisco Us Inc filed Critical Danisco Us Inc

2019-09-24 Publication of BRPI0823193A2 publication Critical patent/BRPI0823193A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0823193A 2008-10-15 2008-10-15 inibidores de protease de bowman birk variantes modificados BRPI0823193A2 (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2008/079951 WO2010044786A1 (en)	2008-10-15	2008-10-15	Modified variant bowman birk protease inhibitors

Publications (1)

Publication Number	Publication Date
BRPI0823193A2 true BRPI0823193A2 (pt)	2019-09-24

Family

ID=40548632

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0823193A BRPI0823193A2 (pt)	2008-10-15	2008-10-15	inibidores de protease de bowman birk variantes modificados

Country Status (9)

Country	Link
EP (1)	EP2344531B1 (pt)
JP (1)	JP5740308B2 (pt)
CN (1)	CN102245635B (pt)
AU (1)	AU2008362898B2 (pt)
BR (1)	BRPI0823193A2 (pt)
CA (1)	CA2740197A1 (pt)
MX (1)	MX2011003803A (pt)
RU (1)	RU2509776C2 (pt)
WO (1)	WO2010044786A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2519245A4 (en) *	2009-12-30	2013-08-28	Solae Llc	PUNIFIED KUNITZ TYPE TRYPSIN INHIBITOR PROTEINS ISOLATED FROM SOY TREATMENT FLOW
CN103069014B (zh)	2010-06-22	2016-06-08	诺维信公司	皮和兽皮的酶法脱毛
WO2012149325A1 (en)	2011-04-29	2012-11-01	Danisco Us Inc.	Detergent compositions containing geobacillus tepidamans mannanase and methods of use thereof
EP2702072A1 (en)	2011-04-29	2014-03-05	Danisco US Inc.	Detergent compositions containing bacillus agaradhaerens mannanase and methods of use thereof
WO2012149333A1 (en)	2011-04-29	2012-11-01	Danisco Us Inc.	Detergent compositions containing bacillus sp. mannanase and methods of use thereof
WO2014100018A1 (en)	2012-12-19	2014-06-26	Danisco Us Inc.	Novel mannanase, compositions and methods of use thereof
CN103710373B (zh) *	2013-12-31	2016-03-30	中山大学	一种原核融合表达载体及其应用
CN106317185B (zh) *	2015-06-23	2019-09-17	首都医科大学	His-Gly-Tyr-Asp，其合成，活性和应用
US20190153417A1 (en)	2015-11-05	2019-05-23	Danisco Us Inc	Paenibacillus sp. mannanases
CN108603183B (zh)	2015-11-05	2023-11-03	丹尼斯科美国公司	类芽孢杆菌属物种和芽孢杆菌属物种甘露聚糖酶
EP3429612A4 (en) *	2016-03-16	2020-04-08	AmideBio LLC	METHODS OF PRODUCING PEPTIDES AND USES THEREOF
CN109689022B (zh) *	2016-09-13	2022-06-14	巴斯夫欧洲公司	低分子量角蛋白水解物
CN108424931A (zh) *	2018-03-29	2018-08-21	内蒙古大学	CRISPR/Cas9技术介导山羊VEGF基因定点整合的方法
CN112553274B (zh) *	2020-12-02	2023-06-13	江南大学	大豆提取物Bowman-Birk inhibitor切割DNA的方法
WO2024050339A1 (en)	2022-09-02	2024-03-07	Danisco Us Inc.	Mannanase variants and methods of use
CN116694606B (zh) *	2023-06-21	2024-03-26	江南大学	一种利用角蛋白酶水解玉米黄粉醇溶蛋白的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3119383A1 (de)	1981-05-15	1982-12-02	Basf Ag, 6700 Ludwigshafen	Verfahren zur herstellung von feinverteilten, pulverfoermigen carotinodpraeparaten
US5411873A (en)	1984-05-29	1995-05-02	Genencor, Inc.	Process for producing heterologous polypeptides
US5679543A (en)	1985-08-29	1997-10-21	Genencor International, Inc.	DNA sequences, vectors and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
US5429950A (en)	1992-03-30	1995-07-04	Genencor International, Inc.	Heterologous gene expression in bacillus subtilis: fusion approach
TW442452B (en) *	1996-03-01	2001-06-23	Akzo Nobel Nv	Serine protease inhibitors having an alkynylamino side chain
CN1214082A (zh)	1996-03-12	1999-04-14	金克克国际有限公司	碱性纤维素酶及其生产方法
US6835550B1 (en)	1998-04-15	2004-12-28	Genencor International, Inc.	Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
SK692001A3 (en) *	1998-07-20	2001-12-03	M & E Biotech As	Novel methods for the identification of ligand and target biomolecules
US20020098524A1 (en)	2000-04-14	2002-07-25	Murray Christopher J.	Methods for selective targeting
US6537968B1 (en)	2000-07-24	2003-03-25	Alphamed Pharmaceuticals Corp	Treatment of lupus erythematosus
CN1875029B (zh) *	2003-11-06	2010-06-16	金克克国际有限公司	蛋白酶抑制剂及其变异体在丝状真菌中的表达
DE602004029393D1 (de) *	2003-11-06	2010-11-11	Danisco Us Inc	Tgf-beta1-bindende und geträgerte peptide
US9084734B2 (en) *	2005-05-05	2015-07-21	Danisco Us Inc.	Peptide personal care compositions and methods for their use
AU2007209761B2 (en)	2006-01-24	2012-05-03	Helix Well Ops (U.K.) Limited	Bore selector
GB0601684D0 (en) *	2006-01-27	2006-03-08	Reckitt Benckiser Uk Ltd	Composition, process for preparation and method of use

2008
- 2008-10-15 BR BRPI0823193A patent/BRPI0823193A2/pt not_active IP Right Cessation
- 2008-10-15 RU RU2011119481/10A patent/RU2509776C2/ru not_active IP Right Cessation
- 2008-10-15 AU AU2008362898A patent/AU2008362898B2/en not_active Ceased
- 2008-10-15 CN CN200880132330.9A patent/CN102245635B/zh not_active Expired - Fee Related
- 2008-10-15 JP JP2011532052A patent/JP5740308B2/ja not_active Expired - Fee Related
- 2008-10-15 CA CA2740197A patent/CA2740197A1/en not_active Abandoned
- 2008-10-15 EP EP08876414.7A patent/EP2344531B1/en not_active Not-in-force
- 2008-10-15 WO PCT/US2008/079951 patent/WO2010044786A1/en active Application Filing
- 2008-10-15 MX MX2011003803A patent/MX2011003803A/es active IP Right Grant

Also Published As

Publication number	Publication date
MX2011003803A (es)	2011-07-04
CA2740197A1 (en)	2010-04-22
RU2011119481A (ru)	2012-11-27
AU2008362898B2 (en)	2013-02-28
JP2012505652A (ja)	2012-03-08
AU2008362898A1 (en)	2010-04-22
EP2344531B1 (en)	2014-12-10
CN102245635B (zh)	2016-08-31
RU2509776C2 (ru)	2014-03-20
WO2010044786A1 (en)	2010-04-22
CN102245635A (zh)	2011-11-16
JP5740308B2 (ja)	2015-06-24
EP2344531A1 (en)	2011-07-20

Publication	Publication Date	Title
BRPI0823193A2 (pt)	2019-09-24	inibidores de protease de bowman birk variantes modificados
LTC2178888I2 (lt)	2018-03-12	Proteazomos inhibitoriai
CY2020023I1 (el)	2020-11-25	Αναστολεiς βητα-λακταμασων
BRPI0807547A2 (pt)	2014-06-17	Inibidores de aspartil protease hetercíclicos
DK2408758T3 (da)	2014-12-01	Krystallin tripeptid-epoxy-keton-protease-inhibitorer
BRPI0922084A2 (pt)	2015-01-27	Composições e métodos compreendendo variantes de serina protease
HK1148739A1 (en)	2011-09-16	Hcv protease inhibitors hcv
EP2139883A4 (en)	2011-06-22	INHIBITORS OF HIV-1 PROTEASE
BRPI0918564A2 (pt)	2015-12-01	inibidores
BR112012001070A2 (pt)	2016-11-22	inibidores de ativação de complementos
BRPI1011267A2 (pt)	2016-03-22	inibidores de protease
BR112012005382A2 (pt)	2016-03-29	inibidores de jak
BRPI0922283A2 (pt)	2015-12-29	inibidores da cistéina protease
EP2313426A4 (en)	2012-01-18	NOVEL PROTEASE INHIBITORS
BRPI0918966A2 (pt)	2015-12-01	inibidores de protease
BRPI0813763A2 (pt)	2014-12-30	Inibidores da protease de cisteína
BRPI0919073A2 (pt)	2016-03-15	inibidores de protease
BRPI0921201A2 (pt)	2016-02-23	válvula de expansão compreendendo meios de polarização
BR112012003044A2 (pt)	2016-04-26	inibidores de catepsina c.
TH101958B (th)	2010-06-25	สารยับยั้งแอสพาร์ติค โปรติเอส
TH0801000834A (th)	2016-11-15	ตัวยับยั้งเฮเทอโรไซคลิก แอสพาร์ทิลโปรตีเอส
TH108801B (th)	2011-06-24	ตัวยับยั้งเรนิน
UA19820S (uk)	2009-12-25	Тумба
UA20126S (uk)	2010-03-10	Тумба
UA19957S (uk)	2010-02-10	Тумба

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application fees: dismissal - article 86 of industrial property law
2020-01-21	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.